Valproic acid
VPA
epilepsy
body
nonalcoholic fatty liver disease
NAFLD
child
obesity
VPA
hyperinsulinemia
insulin resistance
withdrawal
VPA
patient
body
metabolic
endocrine
obesity
hyperinsulinemia
insulin resistance
VPA
development
NAFLD
side effect
VPA
withdrawal
